Variation in tissue outcome of ovine and human engineered heart valve constructs: Relevance for tissue engineering

Regenerative Medicine

Volumn 7, Issue 1, 2012, Pages 59-70

  Van Geemen, Daphne ^a   Driessen Mol, Anita ^a   Grootzwagers, Leonie G M ^a   Soekhradj Soechit, R Sarita ^a   Riem Vis, Paul W ^b   Baaijens, Frank P T ^a   Bouten, Carlijn V C ^a  

^a EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

extracellular matrix; heart valve tissue engineering; mechanical properties; variability

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BIOLOGICAL MARKER; COLLAGEN; MYOSIN HEAVY CHAIN; POLYGLYCOLIC ACID; TISSUE SCAFFOLD; VIMENTIN;

ADULT; ANIMAL CELL; ARTICLE; AUTOTRANSPLANTATION; BIOCHEMICAL COMPOSITION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HEART VALVE SURGERY; HUMAN; HUMAN CELL; HUMAN VERSUS ANIMAL COMPARISON; MALE; MOLECULAR MECHANICS; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RIGIDITY; TISSUE CULTURE TECHNIQUE; TISSUE ENGINEERING; YOUNG MODULUS;

ANIMALS; BIOMECHANICS; CELL COUNT; EXTRACELLULAR MATRIX; FEMALE; HEART VALVE PROSTHESIS; HUMANS; MALE; MIDDLE AGED; MYOFIBROBLASTS; PHENOTYPE; SHEEP, DOMESTIC; TISSUE ENGINEERING;

EID: 83655198639     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.11.100     Document Type: Article

References (42)

1. Lloyd-Jones D, Adams R, Carnethon M et al. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119(3), e21-e181 (2009).
2. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 368(9540), 1005-1011 (2006). (Pubitemid 44353666)
3. Mol A, Smits AI, Bouten CV, Baaijens FP. Tissue engineering of heart valves: advances and current challenges. Expert Rev. Med. Devices 6(3), 259-275 (2009).
4. Mikos AG, Herring SW, Ochareon P et al. Engineering complex tissues. Tissue Eng. 12(12), 3307-3339 (2006). (Pubitemid 46037158)
5. Mendelson K, Schoen FJ. Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann. Biomed. Eng. 34(12), 1799-1819 (2006). (Pubitemid 44770835)
6. El-Hamamsy I, Eryigit Z, Stevens LM et al. Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial. Lancet 376(9740), 524-531 (2010).
7. Vesely I. Heart valve tissue engineering. Circ. Res. 97(8), 743-755 (2005). (Pubitemid 41447124)
8. Schmidt D, Stock UA, Hoerstrup SP. Tissue engineering of heart valves using decellularized xenogeneic or polymeric starter matrices. Philos. Trans. R. Soc. Lond. B Biol. Sci. 362(1484), 1505-1512 (2007). (Pubitemid 47201769)
9. Apte SS, Paul A, Prakash S, Shum-Tim D. Current developments in the tissue engineering of autologous heart valves: moving towards clinical use. Future Cardiol. 7(1), 77-97 (2011).
10. Bouten CV, Dankers PY, Driessen-Mol A, Pedron S, Brizard AM, Baaijens FP. Substrates for cardiovascular tissue engineering. Adv. Drug Deliv. Rev. 63(4-5), 221-241 (2011).
11. Weber B, Emmert MY, Schoenauer R, Brokopp C, Baumgartner L, Hoerstrup SP. Tissue engineering on matrix: future of autologous tissue replacement. Semin. Immunopathol. 33(3), 307-315 (2011).
12. Mol A, Rutten MC, Driessen NJ et al. Autologous human tissue-engineered heart valves: prospects for systemic application. Circulation 114(Suppl. 1), I152-I158 (2006). (Pubitemid 44297144)
13. Hoerstrup SP, Sodian R, Daebritz S et al. Functional living trileaflet heart valves grown in vitro. Circulation 102(19 Suppl. 3), III44-III49 (2000).
14. Rashid ST, Salacinski HJ, Hamilton G, Seifalian AM. The use of animal models in developing the discipline of cardiovascular tissue engineering: a review. Biomaterials 25(9), 1627-1637 (2004). (Pubitemid 38091541)
15. Barnhart GR, Jones M, Ishihara T, Rose DM, Chavez AM, Ferrans VJ. Degeneration and calcification of bioprosthetic cardiac valves. Bioprosthetic tricuspid valve implantation in sheep. Am. J. Pathol. 106(1), 136-139 (1982). (Pubitemid 12222941)
16. Ali ML, Kumar SP, Bjornstad K, Duran CM. The sheep as an animal model for heart valve research. Cardiovasc. Surg. 4(4), 543-549 (1996). (Pubitemid 26258833)
17. Hoerstrup SP, Cummings Mrcs I, Lachat M et al. Functional growth in tissue-engineered living, vascular grafts: follow-up at 100 weeks in a large animal model. Circulation 114(Suppl. 1), I159-I166 (2006). (Pubitemid 44297145)
18. Schnell AM, Hoerstrup SP, Zund G et al. Optimal cell source for cardiovascular tissue engineering: venous vs aortic human myofibroblasts. Thorac. Cardiovasc. Surg. 49(4), 221-225 (2001). (Pubitemid 32776892)
19. Mol A, Van Lieshout MI, Dam-De Veen CG et al. Fibrin as a cell carrier in cardiovascular tissue engineering applications. Biomaterials 26(16), 3113-3121 (2005). (Pubitemid 39647246)
20. Riem Vis P, Bouten CVC, Sluijter JP, Pasterkamp G, Herwerden LV, Kluin J. Platelet-lysate as an autologous alternative for fetal bovine serum in cardiovascular tissue engineering. Tissue Eng. Part A 16(4), 1317-1327 (2010).
21. Puchtler H, Waldrop FS, Valentine LS. Polarization microscopic studies of connective tissue stained with picro-sirius red FBA. Beitr. Pathol. 150(2), 174-187 (1973).
22. Junqueira LCU, Bignolas G, Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochemical J. 11, 447-455 (1979). (Pubitemid 9238595)
23. Cesarone CF, Bolognesi C, Santi L. Improved microfluorometric DNA determination in biological material using 33258 Hoechst. Anal. Biochem. 100(1), 188-197 (1979). (Pubitemid 10157650)
24. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim. Biophys. Acta 883(2), 173-177 (1986). (Pubitemid 16027978)
25. Huszar G, Maiocco J, Naftolin F. Monitoring of collagen and collagen fragments in chromatography of protein mixtures. Anal. Biochem. 105(2), 424-429 (1980). (Pubitemid 11237545)
26. Balguid A, Rubbens MP, Mol A et al. The role of collagen cross-links in biomechanical behavior of human aortic heart valve leaflets - relevance for tissue engineering. Tissue Eng. 13(7), 1501-1511 (2007). (Pubitemid 47105758)
27. Kortsmit J, Driessen NJ, Rutten MC, Baaijens FP. Real time, non-invasive assessment of leaflet deformation in heart valve tissue engineering. Ann. Biomed. Eng. 37(3), 532-541 (2009).
28. Dolezel J, Bartos J, Voglmayr H, Greilhuber J. Nuclear DNA content and genome size of trout and human. Cytometry A 51(2), 127-128; author reply 129 (2003).
29. Buchanan FC, Littlejohn RP, Galloway SM, Crawford AM. Microsatellites and associated repetitive elements in the sheep genome. Mamm. Genome 4(5), 258-264 (1993).
30. Van Geemen D, Vis PW, Soekhradj-Soechit S et al. Decreased mechanical properties of heart valve tissue constructs cultured in platelet lysate as compared with fetal bovine serum. Tissue Eng. Part C Methods 17(5), 607-617 (2011).
31. Riem Vis PW, Sluijter JP, Soekhradj-Soechit RS, Van Herwerden LA, Kluin J, Bouten CV. Sequential use of human-derived medium supplements favors cardiovascular tissue engineering. J. Cell. Mol. Med. doi:10.1111/j.1582-4934. 2011.01351.x (2011) (Epub ahead of print).
32. Grenier G, Remy-Zolghadri M, Guignard R et al. Isolation and culture of the three vascular cell types from a small vein biopsy sample. In Vitro Cell. Dev. Biol. Anim. 39(3-4), 131-139 (2003). (Pubitemid 37204096)
33. Schoen FJ. Heart valve tissue engineering: quo vadis? Curr. Opin. Biotechnol. 22(5), 698-705 (2011).
34. Hjortnaes J, Bouten CV, Van Herwerden LA, Grundeman PF, Kluin J. Translating autologous heart valve tissue engineering from bench to bed. Tissue Eng. Part B Rev. 15(3), 307-317 (2009).
35. Sacks MS, Schoen FJ, Mayer JE. Bioengineering challenges for heart valve tissue engineering. Ann. Rev. Biomed. Eng. 11, 289-313 (2009).
36. Kortsmit J, Driessen NJ, Rutten MC, Baaijens FP. Nondestructive and noninvasive assessment of mechanical properties in heart valve tissue engineering. Tissue Eng. Part A 15(4), 797-806 (2009).
37. Eyden B. The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J. Cell. Mol. Med. 12(1), 22-37 (2008). (Pubitemid 351430454)
38. Ehrlich HP, Allison GM, Leggett M. The myofibroblast, cadherin, alpha smooth muscle actin and the collagen effect. Cell. Biochem. Funct. 24(1), 63-70 (2006). (Pubitemid 43171009)
39. Rabkin-Aikawa E, Farber M, Aikawa M, Schoen FJ. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. J. Heart Valve Dis. 13(5), 841-847 (2004).
40. Aikawa E, Whittaker P, Farber M et al. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation 113(10), 1344-1352 (2006). (Pubitemid 43739456)
41. Merryman WD, Youn I, Lukoff HD et al. Correlation between heart valve interstitial cell stiffness and transvalvular pressure: implications for collagen biosynthesis. Am. J. Physiol. Heart Circ. Physiol. 290(1), H224-H231 (2006).
42. Van Vlimmeren MA, Driessen-Mol A, Oomens CW, Baaijens FP. An in vitro model system to quantify stress generation, compaction, and retraction in engineered heart valve tissue. Tissue Eng. Part C Methods 17(10), 983-991 (2011).